Swissmedic weighing new COVID booster recommendation for children
Swiss drugs regulator Swissmedic said on Tuesday it is reviewing an application from pharmaceutical company Pfizer for a new dosage recommendation for a COVID-19 booster shot for children. The regulator said it was looking at the data submitted and assessing the benefits and risks of recommending a booster shot administered at least six months after basic immunisation for children between ages 5 and 11.
Reuters - May 31, 2022View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/swissmedic-weighing-new-covid-booster-recommendation-children-2022-05-31/